ADAG
Adagene Inc - ADR

208
Mkt Cap
$83.14M
Volume
37,905.00
52W High
$3.16
52W Low
$1.30
PE Ratio
-2.74
ADAG Fundamentals
Price
$1.76
Prev Close
$1.81
Open
$1.76
50D MA
$1.85
Beta
0.13
Avg. Volume
275,457.84
EPS (Annual)
-$0.7426
P/B
2.19
Rev/Employee
$748.23
Loading...
Loading...
News
all
press releases
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven analysts that are currently covering the company, MarketBeat.com...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Average Recommendation of "Moderate Buy" from Brokerages
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat reports. One research...
MarketBeat·26d ago
News Placeholder
Adagene (NASDAQ:ADAG) Upgraded to Strong-Buy at Lifesci Capital
Lifesci Capital raised shares of Adagene to a "strong-buy" rating in a research report on Friday...
MarketBeat·26d ago
News Placeholder
Adagene (NASDAQ:ADAG) Trading 4.1% Higher - Time to Buy?
Adagene (NASDAQ:ADAG) Shares Up 4.1% - Here's What Happened...
MarketBeat·29d ago
News Placeholder
All You Need to Know About Adagene (ADAG) Rating Upgrade to Buy
Adagene (ADAG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·2mo ago
News Placeholder
Are Medical Stocks Lagging Adagene (ADAG) This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and CorMedix (CRMD) have performed compared to their sector so far this year.
Zacks·4mo ago
News Placeholder
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic
Neither the mid-stage nor the late-stage trial of Adagene’s drug needs an arm studying the drug as a monotherapy without Merck’s Keytruda, the company said.
Stocktwits·5mo ago
News Placeholder
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Zacks·6mo ago

Latest ADAG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.